Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.30 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27659160 | 0.97 | TSHR (0.35) | TSHRALDH1A1MAPK1 | |
| SCHEMBL2935124 | 0.84 | TSHR (0.47) | TSHRALDH1A1MAPK1ANPEPERAP2 | |
| SCHEMBL11423545 | 0.80 | — | — | |
| SCHEMBL101393 | 0.80 | — | — | |
| SCHEMBL20836758 | 0.80 | — | — | |
| SCHEMBL15141638 | 0.80 | — | — | |
| SCHEMBL12214929 | 0.80 | — | — | |
| SCHEMBL15142570 | 0.80 | — | — | |
| SCHEMBL19290491 | 0.80 | TSHR (0.33) | TSHRALDH1A1MAPK1ANPEP | |
| SCHEMBL20610092 | 0.80 | TSHR (0.33) | TSHRALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2829555-B1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS INC (JP) | 2018-05-16 | — | — | EP | claimed |
| CN-104203993-B | Process for producing olefin polymer | 三井化学株式会社 | 2016-06-15 | — | — | CN | claimed |
| US-9315602-B2 | Method for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2016-04-19 | — | — | US | claimed |
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260041617-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2026-02-12 | — | — | US | disclosed |
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250177263-A1 | LIPSTICK COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2025-06-05 | — | — | US | disclosed |
| US-20250170037-A1 | EYE MAKEUP COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2025-05-29 | — | — | US | disclosed |
| US-20250152646-A1 | SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS | NOEL ARMAND J (US) | 2025-05-15 | — | — | US | disclosed |
| CN-119855583-A | Composition for cosmetic treatment of keratin fibres | 碧昂赛恩斯公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4496553-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | Biosynthis (FR) | 2025-01-29 | — | — | EP | disclosed |
| CN-1116314-C | Catalyst and processes for polymerization of olefins | MONTELL TECHNOLOGY COMPANY BV (NL) | 2003-07-30 | — | — | CN | disclosed |
| WO-2003051306-A2 | N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| CN-1348459-A | Heterocyclic metallocene compounds and their use in catalyst systems for producing olefin polymers | BASELL TECHNOLOGY CO BV (NL) | 2002-05-08 | — | — | CN | disclosed |
| CN-1347424-A | Metallocene compounds, process for their preparation and their use in catalytic systems for polymerization of olefins | BASELL TECHNOLOGY CO B V (NL) | 2002-05-01 | — | — | CN | disclosed |
| CN-1293677-A | Preparation of bridged metallocenes and use in catalytic systems | MONTELL TECHNOLOGY COMPANY BV (NL) | 2001-05-02 | — | — | CN | disclosed |
| CN-1277618-A | Process for the preparation of substantially amorphous alpha-olefin polymers, compositions containing them and process for the preparation of bridged ligand | MONTELL TECHNOLOGY COMPANY BV (NL) | 2000-12-20 | — | — | CN | disclosed |
| CN-1248270-A | Catalyst and process for olefin polymerization | MONTELL TECHNOLOGY COMPANY BV (NL) | 2000-03-22 | — | — | CN | disclosed |
| US-4761448-A | CARBON MONOXIDE-OLEFIN COPOLYMERS | SHELL OIL COMPANY (US) | 1988-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | CNR2, CNR1, SCD | TSHR 2794/4885ALDH1A1 4135/4885MAPK1 4040/4885 |
| US-20260041617-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | CUTA, AP2M1, LBR | TSHR 612/4885ALDH1A1 134/4885MAPK1 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.